Okazaki Jason A
CEO and President
Okazaki Jason A has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Nov 3, 2026.
On the most recent filing, Okazaki Jason A is listed as CEO and President at ASSEMBLY BIOSCIENCES, INC. Inside the rolling window, Okazaki Jason A reported no open-market purchases and 1 open-market sale totaling $122K in ASMB.
Companies traded
Other insiders at ASMB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$122K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Okazaki Jason A made?
Okazaki Jason A has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Okazaki Jason A trade?
Okazaki Jason A has filed SEC Form 4 disclosures for 1 company, including ASMB.
When was Okazaki Jason A's most recent SEC Form 4 filing?
Okazaki Jason A's most recent SEC Form 4 filing on Tracefour is dated Nov 3, 2026.
What is Okazaki Jason A's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Okazaki Jason A is listed as CEO and President.
What is Okazaki Jason A's total buy and sell value in the current window?
Inside the rolling retention window, Okazaki Jason A bought $0 and sold $122K based on SEC Form 4 filings.
What was Okazaki Jason A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,202 ASMB shares on 2026-11-02, worth $122K, per SEC Form 4 filings.